Product NDC: | 43063-072 |
Proprietary Name: | Spironolactone |
Non Proprietary Name: | Spironolactone |
Active Ingredient(s): | 25 mg/1 & nbsp; Spironolactone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-072 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091426 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100802 |
Package NDC: | 43063-072-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (43063-072-01) |
NDC Code | 43063-072-01 |
Proprietary Name | Spironolactone |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (43063-072-01) |
Product NDC | 43063-072 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Spironolactone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100802 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | SPIRONOLACTONE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |